These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2521651)

  • 1. Secondary depression in panic disorder and agoraphobia. II. Dimensions of depressive symptomatology and their response to treatment.
    Lesser IM; Rubin RT; Rifkin A; Swinson RP; Ballenger JC; Burrows GD; Dupont RL; Noyes R; Pecknold JC
    J Affect Disord; 1989; 16(1):49-58. PubMed ID: 2521651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment.
    Lesser IM; Rubin RT; Pecknold JC; Rifkin A; Swinson RP; Lydiard RB; Burrows GD; Noyes R; DuPont RL
    Arch Gen Psychiatry; 1988 May; 45(5):437-43. PubMed ID: 3282480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks.
    Munjack DJ; Crocker B; Cabe D; Brown R; Usigli R; Zulueta A; McManus M; McDowell D; Palmer R; Leonard M
    J Clin Psychopharmacol; 1989 Feb; 9(1):22-7. PubMed ID: 2651490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychopharmacological treatment of panic disorder and related states: a placebo controlled study of alprazolam.
    Swinson RP; Pecknold JC; Kuch K
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):105-13. PubMed ID: 3628823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPA axis disturbance and treatment outcome in panic disorder.
    Coryell W; Noyes R
    Biol Psychiatry; 1988 Nov; 24(7):762-6. PubMed ID: 3067754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind comparison of alprazolam and adinazolam for panic and phobic disorders.
    Pyke RE; Greenberg HS
    J Clin Psychopharmacol; 1989 Feb; 9(1):15-21. PubMed ID: 2651489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression and panic anxiety: the effect of depressive co-morbidity on response to drug treatment of patients with panic disorder and agoraphobia.
    Klerman GL
    J Psychiatr Res; 1990; 24 Suppl 2():27-41. PubMed ID: 1980697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder.
    Rizley R; Kahn RJ; McNair DM; Frankenthaler LM
    Psychopharmacol Bull; 1986; 22(1):167-72. PubMed ID: 2873609
    [No Abstract]   [Full Text] [Related]  

  • 9. Panic attacks and agoraphobia: low dose clomipramine treatment.
    Gloger S; Grunhaus L; Gladic D; O'Ryan F; Cohen L; Codner S
    J Clin Psychopharmacol; 1989 Feb; 9(1):28-32. PubMed ID: 2651491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agoraphobia and panic disorder: treatment with alprazolam.
    Mark SL
    Tex Med; 1984 Oct; 80(10):50-2. PubMed ID: 6150561
    [No Abstract]   [Full Text] [Related]  

  • 11. Clonazepam in the treatment of panic disorder and agoraphobia.
    Pollack MH; Rosenbaum JF; Tesar GE; Herman JB; Sachs GS
    Psychopharmacol Bull; 1987; 23(1):141-4. PubMed ID: 3110854
    [No Abstract]   [Full Text] [Related]  

  • 12. Fading of therapeutic effects of alprazolam in agoraphobia. Case reports.
    Fava GA
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(1):109-12. PubMed ID: 3363164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment.
    Sheehan DV; Coleman JH; Greenblatt DJ; Jones KJ; Levine PH; Orsulak PJ; Peterson M; Schildkraut JJ; Uzogara E; Watkins D
    J Clin Psychopharmacol; 1984 Apr; 4(2):66-75. PubMed ID: 6142907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three cases of panic disorder with agoraphobia in children.
    Ballenger JC; Carek DJ; Steele JJ; Cornish-McTighe D
    Am J Psychiatry; 1989 Jul; 146(7):922-4. PubMed ID: 2742019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in hypochondriasis with treatment of panic disorder.
    Noyes R; Reich J; Clancy J; O'Gorman TW
    Br J Psychiatry; 1986 Nov; 149():631-5. PubMed ID: 3814956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alprazolam in the treatment of panic attack patients with and without major depression.
    Pyke RE; Kraus M
    J Clin Psychiatry; 1988 Feb; 49(2):66-8. PubMed ID: 3338978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taper withdrawal studies with alprazolam in patients with panic disorder and agoraphobia.
    Pecknold JC; Swinson RP
    Psychopharmacol Bull; 1986; 22(1):173-6. PubMed ID: 3726063
    [No Abstract]   [Full Text] [Related]  

  • 18. Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment.
    Maier W; Rosenberg R; Argyle N; Buller R; Roth M; Brandon S; Benkert O
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(1):22-30. PubMed ID: 1832302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety.
    Noyes R; DuPont RL; Pecknold JC; Rifkin A; Rubin RT; Swinson RP; Ballenger JC; Burrows GD
    Arch Gen Psychiatry; 1988 May; 45(5):423-8. PubMed ID: 3358644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment-emergent depression with antidepressants in panic disorder.
    Aronson TA
    Compr Psychiatry; 1989; 30(3):267-71. PubMed ID: 2731426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.